📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Alpha-9 Theranostics

1.1 - Company Overview

Alpha-9 Theranostics Logo

Alpha-9 Theranostics

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of radiotherapeutics for solid and hematologic malignancies, developing peptide-based radiopharmaceuticals that combine binders, linkers, chelators, and radioisotopes for selective radiation delivery. Services include target selection, imaging and dosimetry studies, therapy studies, and R&D supported by Vancouver research facilities.

Products and services

  • Radiopharmaceuticals: Targeted assemblies architected to deliver radiation selectively to cancer cells, comprising binders, linkers, chelators, and radioisotopes for optimized selectivity and stability
  • Therapy studies: High-energy-isotope-based patient treatments guided by human imaging and dosimetry data, executed in trials analogous to Phase I/II to evaluate therapeutic impact
  • Target selection: Differentiated-expression-guided target prioritization to maximize radioactive payload delivery to tumor cells while minimizing exposure to healthy organs during radiopharmaceutical development

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Alpha-9 Theranostics

Theseus Pharmaceuticals Logo

Theseus Pharmaceuticals

HQ: United States Website
  • Description: Provider of technology-based pharmaceutical offerings.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theseus Pharmaceuticals company profile →
Cellerant Therapeutics Logo

Cellerant Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage cell- and antibody-based immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellerant Therapeutics company profile →
Provectus Biopharmaceuticals Logo

Provectus Biopharmaceuticals

HQ: United States Website
  • Description: Provider of investigational therapies for skin, liver, and breast cancers and dermatological conditions, including PV-10, an intratumoral immunotherapy using rose bengal disodium for solid tumors such as melanoma, and PH-10, a topical rose bengal disodium formulation under study.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Provectus Biopharmaceuticals company profile →
Medite Cancer Diagnostics Logo

Medite Cancer Diagnostics

HQ: United States Website
  • Description: Provider of development, manufacture, and distribution as a mid-sized industrial corporation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medite Cancer Diagnostics company profile →
Cizzle Biotechnology Logo

Cizzle Biotechnology

HQ: United Kingdom Website
  • Description: Provider of cancer diagnostics for early detection of different forms of lung cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cizzle Biotechnology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Alpha-9 Theranostics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Alpha-9 Theranostics

2.2 - Growth funds investing in similar companies to Alpha-9 Theranostics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Alpha-9 Theranostics

4.2 - Public trading comparable groups for Alpha-9 Theranostics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Alpha-9 Theranostics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Alpha-9 Theranostics

What does Alpha-9 Theranostics do?

Alpha-9 Theranostics is a provider of radiotherapeutics for solid and hematologic malignancies, developing peptide-based radiopharmaceuticals that combine binders, linkers, chelators, and radioisotopes for selective radiation delivery. Services include target selection, imaging and dosimetry studies, therapy studies, and R&D supported by Vancouver research facilities.

Who are Alpha-9 Theranostics's competitors?

Alpha-9 Theranostics's competitors and similar companies include Theseus Pharmaceuticals, Cellerant Therapeutics, Provectus Biopharmaceuticals, Medite Cancer Diagnostics, and Cizzle Biotechnology.

Where is Alpha-9 Theranostics headquartered?

Alpha-9 Theranostics is headquartered in Canada.

How many employees does Alpha-9 Theranostics have?

Alpha-9 Theranostics has 1,000 employees 🔒.

When was Alpha-9 Theranostics founded?

Alpha-9 Theranostics was founded in 2010 🔒.

What sector and industry vertical is Alpha-9 Theranostics in?

Alpha-9 Theranostics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Alpha-9 Theranostics

Who are the top strategic acquirers in Alpha-9 Theranostics's sector and industry

Top strategic M&A buyers and acquirers in Alpha-9 Theranostics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Alpha-9 Theranostics?

Top strategic M&A buyers groups and sectors for Alpha-9 Theranostics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Alpha-9 Theranostics's sector and industry vertical

Which are the top PE firms investing in Alpha-9 Theranostics's sector and industry vertical?

Top PE firms investing in Alpha-9 Theranostics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Alpha-9 Theranostics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Alpha-9 Theranostics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Alpha-9 Theranostics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Alpha-9 Theranostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Alpha-9 Theranostics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Alpha-9 Theranostics?

The key public trading comparables and valuation benchmarks for Alpha-9 Theranostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Alpha-9 Theranostics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Alpha-9 Theranostics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Alpha-9 Theranostics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Alpha-9 Theranostics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Alpha-9 Theranostics's' sector and industry vertical?

Access recent funding rounds and capital raises in Alpha-9 Theranostics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Alpha-9 Theranostics